Principal Securities, Inc. Sarepta Therapeutics, Inc. Transaction History
Principal Securities, Inc.
- $5.32 Trillion
- Q2 2025
A detailed history of Principal Securities, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 487 shares of SRPT stock, worth $10,767. This represents 0.0% of its overall portfolio holdings.
Number of Shares
487
Previous 221
120.36%
Holding current value
$10,767
Previous $26.9 Million
69.01%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
462Shares Held
82.5MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$228 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$203 Million0.0% of portfolio
-
State Street Corp Boston, MA4.7MShares$104 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$99 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$55.9 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.94B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...